Intravitreal bevacizumab in diabetic retinopathy. Recommendations from the Pan-American Collaborative Retina Study Group (PACORES): The 2016 knobloch lecture

The advent of intravitreal anti-vascular endothelial growth factor (anti-VEGF) medications has revolutionized the treatment of diabetic eye diseases. Herein, we report the outcomes of clinical studies carried out by the Pan-American Collaborative Retina Study Group (PACORES), with a specific focus o...

Full description

Autores:

Tipo de recurso:

Fecha de publicación:: 2018

Institución:: Universidad del Rosario

Repositorio:: Repositorio EdocUR - U. Rosario

Idioma:: eng

id	EDOCUR2_75edc4237b50b343947aea5c7204523e
oai_identifier_str	oai:repository.urosario.edu.co:10336/23077
network_acronym_str	EDOCUR2
network_name_str	Repositorio EdocUR - U. Rosario
repository_id_str
dc.title.spa.fl_str_mv	Intravitreal bevacizumab in diabetic retinopathy. Recommendations from the Pan-American Collaborative Retina Study Group (PACORES): The 2016 knobloch lecture
title	Intravitreal bevacizumab in diabetic retinopathy. Recommendations from the Pan-American Collaborative Retina Study Group (PACORES): The 2016 knobloch lecture
spellingShingle	Intravitreal bevacizumab in diabetic retinopathy. Recommendations from the Pan-American Collaborative Retina Study Group (PACORES): The 2016 knobloch lecture Angiogenesis inhibitor Bevacizumab Adjuvant chemotherapy Diabetic retinopathy Human Intravitreal drug administration Macular edema Preoperative care Angiogenesis inhibitors Bevacizumab Diabetic retinopathy Humans Intravitreal injections Macular edema Preoperative care Bevacizumab Diabetic macular edema Intravitreal injections Proliferative diabetic retinopathy Tractional retinal detachment adjuvant Chemotherapy
title_short	Intravitreal bevacizumab in diabetic retinopathy. Recommendations from the Pan-American Collaborative Retina Study Group (PACORES): The 2016 knobloch lecture
title_full	Intravitreal bevacizumab in diabetic retinopathy. Recommendations from the Pan-American Collaborative Retina Study Group (PACORES): The 2016 knobloch lecture
title_fullStr	Intravitreal bevacizumab in diabetic retinopathy. Recommendations from the Pan-American Collaborative Retina Study Group (PACORES): The 2016 knobloch lecture
title_full_unstemmed	Intravitreal bevacizumab in diabetic retinopathy. Recommendations from the Pan-American Collaborative Retina Study Group (PACORES): The 2016 knobloch lecture
title_sort	Intravitreal bevacizumab in diabetic retinopathy. Recommendations from the Pan-American Collaborative Retina Study Group (PACORES): The 2016 knobloch lecture
dc.subject.keyword.spa.fl_str_mv	Angiogenesis inhibitor Bevacizumab Adjuvant chemotherapy Diabetic retinopathy Human Intravitreal drug administration Macular edema Preoperative care Angiogenesis inhibitors Bevacizumab Diabetic retinopathy Humans Intravitreal injections Macular edema Preoperative care Bevacizumab Diabetic macular edema Intravitreal injections Proliferative diabetic retinopathy Tractional retinal detachment
topic	Angiogenesis inhibitor Bevacizumab Adjuvant chemotherapy Diabetic retinopathy Human Intravitreal drug administration Macular edema Preoperative care Angiogenesis inhibitors Bevacizumab Diabetic retinopathy Humans Intravitreal injections Macular edema Preoperative care Bevacizumab Diabetic macular edema Intravitreal injections Proliferative diabetic retinopathy Tractional retinal detachment adjuvant Chemotherapy
dc.subject.keyword.eng.fl_str_mv	adjuvant Chemotherapy
description	The advent of intravitreal anti-vascular endothelial growth factor (anti-VEGF) medications has revolutionized the treatment of diabetic eye diseases. Herein, we report the outcomes of clinical studies carried out by the Pan-American Collaborative Retina Study Group (PACORES), with a specific focus on the efficacy of intravitreal bevacizumab in the management of diabetic macular edema and proliferative diabetic retinopathy. We will also discuss the use of intravitreal bevaci-zumab as a preoperative, adjuvant therapy before vitrectomy for prolif-erative diabetic retinopathy. Copyright © 2017 by Asia Pacific Academy of Ophthalmology.
publishDate	2018
dc.date.created.spa.fl_str_mv	2018
dc.date.accessioned.none.fl_str_mv	2020-05-25T23:59:38Z
dc.date.available.none.fl_str_mv	2020-05-25T23:59:38Z
dc.type.eng.fl_str_mv	article
dc.type.coarversion.fl_str_mv	http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv	http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv	Artículo
dc.identifier.doi.none.fl_str_mv	https://doi.org/10.22608/APO.2017466
dc.identifier.issn.none.fl_str_mv	21620989
dc.identifier.uri.none.fl_str_mv	https://repository.urosario.edu.co/handle/10336/23077
url	https://doi.org/10.22608/APO.2017466 https://repository.urosario.edu.co/handle/10336/23077
identifier_str_mv	21620989
dc.language.iso.spa.fl_str_mv	eng
language	eng
dc.relation.citationEndPage.none.fl_str_mv	39
dc.relation.citationIssue.none.fl_str_mv	No. 1
dc.relation.citationStartPage.none.fl_str_mv	36
dc.relation.citationTitle.none.fl_str_mv	Asia-Pacific Journal of Ophthalmology
dc.relation.citationVolume.none.fl_str_mv	Vol. 7
dc.relation.ispartof.spa.fl_str_mv	Asia-Pacific Journal of Ophthalmology, ISSN:21620989, Vol.7, No.1 (2018); pp. 36-39
dc.relation.uri.spa.fl_str_mv	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044056870&doi=10.22608%2fAPO.2017466&partnerID=40&md5=0cc533e1f1354ee7e15b351f2196ef83
dc.rights.coar.fl_str_mv	http://purl.org/coar/access_right/c_abf2
dc.rights.acceso.spa.fl_str_mv	Abierto (Texto Completo)
rights_invalid_str_mv	Abierto (Texto Completo) http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv	application/pdf
dc.publisher.spa.fl_str_mv	Asia-Pacific Academy of Ophthalmology
institution	Universidad del Rosario
dc.source.instname.spa.fl_str_mv	instname:Universidad del Rosario
dc.source.reponame.spa.fl_str_mv	reponame:Repositorio Institucional EdocUR
bitstream.url.fl_str_mv	https://repository.urosario.edu.co/bitstreams/4779634f-4272-449b-bd1c-db6716e6a08a/download https://repository.urosario.edu.co/bitstreams/b12201f1-ad32-464d-b7b2-cc47b4533e23/download https://repository.urosario.edu.co/bitstreams/9633a71a-d2aa-4a17-8280-80ceee667649/download
bitstream.checksum.fl_str_mv	faf1563bacb2fedf222807a18fbd951f 07f7cb0614150a3f403d34b1a0ffbef3 c7d8092c1edb24f64c1829731606f086
bitstream.checksumAlgorithm.fl_str_mv	MD5 MD5 MD5
repository.name.fl_str_mv	Repositorio institucional EdocUR
repository.mail.fl_str_mv	edocur@urosario.edu.co
_version_	1814167653849235456
spelling	fe6aaae7-67b3-4127-96dc-380cb793b059-1887b0dba-eaad-4040-af9c-973cbb044995-16eef1ef0-a1e8-424f-9136-ab7504b07422-1554ca067-261c-4578-b8cd-ff756b52d3b1-152511aca-5785-4342-b1af-05e66e0bbd7b-1aeede2a6-4012-41e0-ac02-3d12e3cfcf93-1a6f804fc-98cb-4b5f-9586-b10ce7060834-1b82b32d7-49d2-4e06-8adc-d024a814a641-18ffc9806-babd-4184-9f8d-a776baa29e9f-19eb4ce8c-09f7-4536-8c6b-45567252030f-16c10f24a-0569-4cea-acdc-40c921d02401-1a25db0a9-dd7f-492a-8e78-2d76a969dd89-11e4daeee-b1e8-4738-8f1b-62c17388ef7f-1f729ce1e-9d26-485b-86d8-6b1a22793c4d-1d32824e1-5246-415b-ad2e-4b782b33abe7-11a20bbe6-3f20-4d80-ab11-bfe9861b5d6c-1089e58a6-4ffd-4f94-bc6e-c35bcdcd0100-1f91728f0-5d4d-4d13-a9c1-1aeac26d724d-12fea4adf-3fa6-4ca6-b4ce-2e28cfc8210c-106e24700-f187-46cb-b338-20a13234d5c1-1d29f403c-a9d6-45ce-b1d0-4b15c658e3b5-19e7d0ab0-ecef-4b88-90bd-ce6d3395e4a6-13bff28ed-68a5-4544-a616-dd1ed5733600-174875c50-bf4b-4d32-a525-5a79a5fc86ce-10d21312d-3252-44e0-85ba-80b71c1499fa-13d93a557-6845-4de1-b102-3636e42961a8-18f615ed1-ac9d-4ef7-af83-b73a34bc366d-1e82d3b9c-7a14-4fe4-bd2a-82a8bd5daac4-1266491fa-78bf-44fd-a1c1-367a0d61acce-14a5f74b7-588d-45b3-9f28-1bd04daa5f2c-117acf48c-5282-40d6-877d-a95dbcd55c6d-19021aaf1-4e71-4843-b042-9fcea4c5e73b-13a0805f7-c364-4590-bad7-ef31bf968c08-1b4df1100-532e-4c22-950d-fcd750d885c1-12ea4e67d-a293-4a92-a479-31b40bf1bda3-1468293c6-c5f8-4811-bd38-ddc3143573e7-1d03d656a-e57d-422f-8b9a-4def99078f3e-1d7fe2c01-e58a-4de3-8b0e-34709a364701-18220e0a9-0454-4178-90b9-d57eb4ae42fb-1fc7a1469-4d02-42f5-a23a-9ac6662a04bd-139abaaa4-90be-4ea1-bfef-b3f1f3fd1696-148fa86a7-464b-42bd-a1b1-0eebe439df40-11a34b37a-69b7-4004-baeb-3b9d2e85dd05-133baad2f-71f0-41f9-b3cc-0e89ef0b7711-19d6e770c-af66-492a-babf-49edbf48b4f4-1dc79e10e-84ea-4d09-94ee-3dd235f9166f-168bf4a93-2e61-43e2-ae7f-ebc361f64234-1e982d410-c073-4210-be50-890548540cfa6002020-05-25T23:59:38Z2020-05-25T23:59:38Z2018The advent of intravitreal anti-vascular endothelial growth factor (anti-VEGF) medications has revolutionized the treatment of diabetic eye diseases. Herein, we report the outcomes of clinical studies carried out by the Pan-American Collaborative Retina Study Group (PACORES), with a specific focus on the efficacy of intravitreal bevacizumab in the management of diabetic macular edema and proliferative diabetic retinopathy. We will also discuss the use of intravitreal bevaci-zumab as a preoperative, adjuvant therapy before vitrectomy for prolif-erative diabetic retinopathy. Copyright © 2017 by Asia Pacific Academy of Ophthalmology.application/pdfhttps://doi.org/10.22608/APO.201746621620989https://repository.urosario.edu.co/handle/10336/23077engAsia-Pacific Academy of Ophthalmology39No. 136Asia-Pacific Journal of OphthalmologyVol. 7Asia-Pacific Journal of Ophthalmology, ISSN:21620989, Vol.7, No.1 (2018); pp. 36-39https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044056870&doi=10.22608%2fAPO.2017466&partnerID=40&md5=0cc533e1f1354ee7e15b351f2196ef83Abierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURAngiogenesis inhibitorBevacizumabAdjuvant chemotherapyDiabetic retinopathyHumanIntravitreal drug administrationMacular edemaPreoperative careAngiogenesis inhibitorsBevacizumabDiabetic retinopathyHumansIntravitreal injectionsMacular edemaPreoperative careBevacizumabDiabetic macular edemaIntravitreal injectionsProliferative diabetic retinopathyTractional retinal detachmentadjuvantChemotherapyIntravitreal bevacizumab in diabetic retinopathy. Recommendations from the Pan-American Collaborative Retina Study Group (PACORES): The 2016 knobloch lecturearticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Arevalo J.F.Liu T.Y.A.Wu L.Lasave A.F.Farah M.Maia M.Penha F.M.Rodrigues E.B.Morales-Canton V.Fromow-Guerra J.Guerrero-Naranjo J.L.Dalma-Weiszhausz J.Velez-Montoya R.Quiroz-Mercado H.Rodriguez F.J.Gomez F.E.Brieke A.C.Goveto A.Berrocal M.H.Cruz-Villegas V.Graue-Wiechers F.Lozano-Rechy D.Fulda-Graue E.Roca J.A.Hernández A.Saravia M.J.Schlaen A.Rojas J.Ingolotti M.Avila M.Carla L.Cardillo J.Jorge R.Carpentier C.Verdaguer J.Verdaguer J.I.Sepúlveda G.Alezzandrini A.Garcia B.Zas M.Gallego-Pinazo R.Diaz-Llopis M.Dolz-Marco R.Figueroa M.Contreras I.Ruiz-Casas D.Pan-American Collaborative Retina Study Group (PACORES)Pan-American Collaborative Retina Study Group (PACORES)ORIGINALIntravitreal_Bevacizumab_in_Diabetic_Retinopathy_6.pdfapplication/pdf424025https://repository.urosario.edu.co/bitstreams/4779634f-4272-449b-bd1c-db6716e6a08a/downloadfaf1563bacb2fedf222807a18fbd951fMD51TEXTIntravitreal_Bevacizumab_in_Diabetic_Retinopathy_6.pdf.txtIntravitreal_Bevacizumab_in_Diabetic_Retinopathy_6.pdf.txtExtracted texttext/plain25249https://repository.urosario.edu.co/bitstreams/b12201f1-ad32-464d-b7b2-cc47b4533e23/download07f7cb0614150a3f403d34b1a0ffbef3MD52THUMBNAILIntravitreal_Bevacizumab_in_Diabetic_Retinopathy_6.pdf.jpgIntravitreal_Bevacizumab_in_Diabetic_Retinopathy_6.pdf.jpgGenerated Thumbnailimage/jpeg5258https://repository.urosario.edu.co/bitstreams/9633a71a-d2aa-4a17-8280-80ceee667649/downloadc7d8092c1edb24f64c1829731606f086MD5310336/23077oai:repository.urosario.edu.co:10336/230772022-05-02 07:37:20.894156https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co

Intravitreal bevacizumab in diabetic retinopathy. Recommendations from the Pan-American Collaborative Retina Study Group (PACORES): The 2016 knobloch lecture

Publicaciones similares